Aetna Announces Appearance at UBS 21st Annual Global Healthcare Services Conference

HARTFORD, Conn.--(BUSINESS WIRE)-- Aetna (NYSE: AET) announced today that Mark T. Bertolini, CEO and president, is scheduled to make a presentation at the UBS 21st Annual Global Healthcare Services Conference on February 8, 2011, in New York, NY.

Aetna’s presentation is scheduled to begin at 10:30 a.m. EST. Investors, analysts and the general public are invited to listen to this presentation over the Internet via Aetna’s Investor Information link at www.aetna.com/investor. To listen to this presentation live on the Internet, visit Aetna’s web site prior to the presentation to download and install any necessary audio software. A webcast replay will be available via Aetna’s Investor Information link at www.aetna.com/investor, beginning approximately two hours after the event, for 14 days.

Anyone listening to the presentation is encouraged to read Aetna’s annual and quarterly reports filed with the Securities and Exchange Commission for a discussion of Aetna's historical results of operations and financial condition. Information reconciling certain financial and other measures that may be disclosed in the presentation to relevant GAAP measures will be available prior to the presentation via the Investor Information portion of Aetna’s web site.

About Aetna

Aetna is one of the nation’s leading diversified health care benefits companies, serving approximately 35.4 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see www.aetna.com. To learn more about Aetna's innovative online tools, visit www.aetnatools.com.



CONTACT:

Aetna
Media Contact:
Fred Laberge, 860-273-4788
[email protected]
or
Investor Contact:
Thomas Cowhey, 860-273-2402
[email protected]

KEYWORDS:   United States  North America  Connecticut

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Other Health  Professional Services  Insurance

MEDIA:

Logo
 Logo

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.